nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—UGT2B17—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00389	0.00389	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00383	0.00383	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00381	0.00381	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00379	0.00379	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00379	0.00379	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00376	0.00376	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00374	0.00374	CbGpPWpGaD
Losartan—UGT2B7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00374	0.00374	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0037	0.0037	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00369	0.00369	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00365	0.00365	CbGpPWpGaD
Losartan—AGTR1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00364	0.00364	CbGpPWpGaD
Losartan—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00355	0.00355	CbGpPWpGaD
Losartan—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0035	0.0035	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00348	0.00348	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00344	0.00344	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00332	0.00332	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00326	0.00326	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00322	0.00322	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00315	0.00315	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—COMT—attention deficit hyperactivity disorder	0.0031	0.0031	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00308	0.00308	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00308	0.00308	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00307	0.00307	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00306	0.00306	CbGpPWpGaD
Losartan—UGT1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00304	0.00304	CbGpPWpGaD
Losartan—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00303	0.00303	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00301	0.00301	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.003	0.003	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0029	0.0029	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00285	0.00285	CbGpPWpGaD
Losartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00282	0.00282	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00282	0.00282	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00279	0.00279	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00273	0.00273	CbGpPWpGaD
Losartan—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0027	0.0027	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00262	0.00262	CbGpPWpGaD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00262	0.00262	CbGpPWpGaD
Losartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00247	0.00247	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00245	0.00245	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00241	0.00241	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00238	0.00238	CbGpPWpGaD
Losartan—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00211	0.00211	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00208	0.00208	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00199	0.00199	CbGpPWpGaD
Losartan—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00193	0.00193	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00192	0.00192	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0019	0.0019	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00189	0.00189	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00187	0.00187	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00186	0.00186	CbGpPWpGaD
Losartan—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00185	0.00185	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00184	0.00184	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00182	0.00182	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00182	0.00182	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.0018	0.0018	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00174	0.00174	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00172	0.00172	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00169	0.00169	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00166	0.00166	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00166	0.00166	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00165	0.00165	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00165	0.00165	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00164	0.00164	CbGpPWpGaD
Losartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00163	0.00163	CbGpPWpGaD
Losartan—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.00163	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00162	0.00162	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00161	0.00161	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00161	0.00161	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00161	0.00161	CbGpPWpGaD
Losartan—CYP2C8—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0016	0.0016	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00159	0.00159	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00158	0.00158	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00155	0.00155	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00154	0.00154	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00149	0.00149	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00148	0.00148	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00146	0.00146	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00145	0.00145	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00145	0.00145	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00144	0.00144	CbGpPWpGaD
Losartan—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00143	0.00143	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00139	0.00139	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00139	0.00139	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00136	0.00136	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00135	0.00135	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00133	0.00133	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—EP300—attention deficit hyperactivity disorder	0.00133	0.00133	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00132	0.00132	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00131	0.00131	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.0013	0.0013	CbGpPWpGaD
Losartan—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0013	0.0013	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00126	0.00126	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00124	0.00124	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00124	0.00124	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00121	0.00121	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00119	0.00119	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00119	0.00119	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00117	0.00117	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00115	0.00115	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00115	0.00115	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00113	0.00113	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00112	0.00112	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00111	0.00111	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00108	0.00108	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00107	0.00107	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00107	0.00107	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00105	0.00105	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00104	0.00104	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00101	0.00101	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000978	0.000978	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000977	0.000977	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000957	0.000957	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000948	0.000948	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000943	0.000943	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000908	0.000908	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000902	0.000902	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000879	0.000879	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00087	0.00087	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000869	0.000869	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000869	0.000869	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000864	0.000864	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000864	0.000864	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000858	0.000858	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000855	0.000855	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000855	0.000855	CbGpPWpGaD
Losartan—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000854	0.000854	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000854	0.000854	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000814	0.000814	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000796	0.000796	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000796	0.000796	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000795	0.000795	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000795	0.000795	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000783	0.000783	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000765	0.000765	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000762	0.000762	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000757	0.000757	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000728	0.000728	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000718	0.000718	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000713	0.000713	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000695	0.000695	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000692	0.000692	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000691	0.000691	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000663	0.000663	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000661	0.000661	CbGpPWpGaD
Losartan—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000659	0.000659	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—COMT—attention deficit hyperactivity disorder	0.000648	0.000648	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000643	0.000643	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000637	0.000637	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000606	0.000606	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000606	0.000606	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000592	0.000592	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000578	0.000578	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000557	0.000557	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000557	0.000557	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00054	0.00054	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000528	0.000528	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000528	0.000528	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000527	0.000527	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000523	0.000523	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00052	0.00052	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000483	0.000483	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000482	0.000482	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000479	0.000479	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000465	0.000465	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000461	0.000461	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000458	0.000458	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000458	0.000458	CbGpPWpGaD
Losartan—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000455	0.000455	CbGpPWpGaD
Losartan—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000455	0.000455	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00045	0.00045	CbGpPWpGaD
Losartan—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000448	0.000448	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000422	0.000422	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000419	0.000419	CbGpPWpGaD
Losartan—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000416	0.000416	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000408	0.000408	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000408	0.000408	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000402	0.000402	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000402	0.000402	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000399	0.000399	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000399	0.000399	CbGpPWpGaD
Losartan—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000392	0.000392	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000374	0.000374	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000372	0.000372	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000372	0.000372	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000366	0.000366	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000366	0.000366	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000365	0.000365	CbGpPWpGaD
Losartan—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000364	0.000364	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000356	0.000356	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000348	0.000348	CbGpPWpGaD
Losartan—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000346	0.000346	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000341	0.000341	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000327	0.000327	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000327	0.000327	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	0.00032	0.00032	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000319	0.000319	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000318	0.000318	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000318	0.000318	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000318	0.000318	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000313	0.000313	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.000311	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000308	0.000308	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000303	0.000303	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000298	0.000298	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000295	0.000295	CbGpPWpGaD
Losartan—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000292	0.000292	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000291	0.000291	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000283	0.000283	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000278	0.000278	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	0.000277	0.000277	CbGpPWpGaD
Losartan—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000276	0.000276	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000275	0.000275	CbGpPWpGaD
Losartan—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000274	0.000274	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000267	0.000267	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000265	0.000265	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000254	0.000254	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000247	0.000247	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000246	0.000246	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000246	0.000246	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000246	0.000246	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000242	0.000242	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000242	0.000242	CbGpPWpGaD
Losartan—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000242	0.000242	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00024	0.00024	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000238	0.000238	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000226	0.000226	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000226	0.000226	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000225	0.000225	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000224	0.000224	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000217	0.000217	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000207	0.000207	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000196	0.000196	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000193	0.000193	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000191	0.000191	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000187	0.000187	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000186	0.000186	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000149	0.000149	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000148	0.000148	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	0.000137	0.000137	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	0.000119	0.000119	CbGpPWpGaD
Losartan—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	0.000118	0.000118	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	0.000106	0.000106	CbGpPWpGaD
Losartan—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000104	0.000104	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	9.68e-05	9.68e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	8.27e-05	8.27e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	6.38e-05	6.38e-05	CbGpPWpGaD
